{"prompt": "['CONFIDENTIAL', 'Verrica Pharmaceuticals Inc.', 'VP-102', 'Clinical Protocol: VP-102-103', '10.', 'Rabkin SW, Friesen JM, Ferris JA, Fung HY. A model of cardiac arrhythmias', 'and sudden death: cantharidin-induced toxic cardiomyopathy. J Pharmacol Exp', 'Ther 1979;210(1):43-50.', '11.', 'Neumann J, Herzig S, Boknik P, Apel M, Kaspareit G, Schmitz W, et al. On', 'the cardiac contractile, biochemical and electrophysiological effects of', 'cantharidin, a phosphatase inhibitor. J Pharmacol Exp Ther 1995;274(1):530-', '539.', '12.', 'Linck B, Boknik P, Knapp J, Muller FU, Neumann J, Schmitz W, et al. Effects', 'of cantharidin on force of contraction and phosphatase activity in nonfailing', 'and failing human hearts. Br J Pharmacol 1996;119(3):545-550.', '13.', 'Knapp J, Boknik P, Linck B, Luss H, Muller FU, Nacke P, et al. The effect of', 'the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated', 'vasorelaxation. Br J Pharmacol 1997;120(3):421-428.', '14.', 'Hong SJ. Inhibition of mouse neuromuscular transmission and contractile', 'function by okadaic acid and cantharidin. Br J Pharmacol 2000;130(6):1211-', '1218.', '15.', 'Knapp J, Boknik P, Huke S, Gombosova I, Linck B, Luss H, et al. Contractility', 'and inhibition of protein phosphatases by cantharidin. Gen Pharmacol', '1998;31(5):729-733', '16.', 'Schairer DO. Interim analysis of a double-blind, placebo-controlled study of', 'topical cantharidin for the treatment of molluscum contagiosum. Pediatr', 'Dermatol 2015;32:758.', '17.', 'Dosal C, Stewart PW, Lin JA, Williams CS, Morrell DS. Cantharidin for the', 'treatment of molluscum contagiosum: a prospective, double-blinded, placebo-', 'controlled trial. Pediatr Dermatol 2014;31(4):440-449.', '18.', 'The British Pharmaceutical Codex. General Monographs. Cantharidin. 1949:', '2010.', 'Page 66']['CONFIDENTIAL', 'Verrica Pharmaceuticals Inc.', 'VP-102', 'Clinical Protocol: VP-102-103', '19.', 'Jahnke MD. Cantharidin on the Face? Yes, it is Safe! A Retrospective Case', 'Series on the Treatment of Pediatric Facial Molluscum Contagiosum. Pediatr', 'Dermatol 2015;32:756.', '20.', 'Moye VA, Cathcart S, Morrell DS. Safety of cantharidin: a retrospective review', 'of cantharidin treatment in 405 children with molluscum contagiosum. Pediatr', 'Dermatol 2014;31(4):450-454.', '21.', 'Cathcart S, Coloe J, Morrell DS. Parental satisfaction, efficacy, and adverse', 'events in 54 patients treated with cantharidin for molluscum contagiosum', 'infection. Clin Pediatr (Phila) 2009;48(2):161-165', '22.', 'Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum:', 'experience with cantharidin therapy in 300 patients. J Am Acad Dermatol', '2000;43(3):503-507.', '23.', 'Hanna D, Hatami A, Powell J, Marcoux D, Maari C, Savard P, et al. A', 'prospective randomized trial comparing the efficacy and adverse effects of four', 'recognized treatments of molluscum contagiosum in children. Pediatr Dermatol', '2006;23(6):574-579.', '24.', 'Funt TR. Cantharidin treatment of molluscum contagiosum. Arch Dermatol', '1961;83:504-505.', '8.1', 'UNPUBLISHED MANUSCRIPT', 'Garelik J, Schairer D, Hwang H, Viola K, Cohen S. Safety and efficacy of topical', 'cantharidin for the treatment of pediatric molluscum contagiosum: a prospective,', 'randomized, double-blind, placebo-controlled trial.', 'Page 67']\n\n###\n\n", "completion": "END"}